Fierce Biotech: Digital Stethoscope Maker Eko Nets $65M To Develop Home Telehealth Offerings
Posted in
Newsroom
The proceeds will be used to expand the use of Eko's devices and AI capabilities.
As the use of telehealth continues to surge-promising a way to deliver distanced care in spite of the coronavirus, and potentially a new normal in a post-pandemic world-the makers of a digital, connected stethoscope have raised new funds to expand its remote disease screening programs.
Eko secured $65 million in a series C venture capital round, led by Highland Capital Partners and Questa Capital, alongside additional backers in Artis Ventures, DigiTx Partners, NTTVC, 3M Ventures and other investors.
Read more at Fierce Biotech
